Drug · DIN 02264366
EUTHYROX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 9, 2026; first marketed May 19, 2005.
- Drug Identification Number (DIN)
- 02264366
- Company (DIN owner)
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levothyroxine sodium H03AA01
- Class
- Human
- Record last updated
- April 1, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVOTHYROXINE SODIUM | 88 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 10, 2008: NOC 9888New Drug Submission (NDS) · Manufacturer name change
- May 19, 2005: NOC 6807Supplement to a New Drug Submission (SNDS) · Product name change from gen-levothyroxine
- February 14, 2005: NOC 6285New Drug Submission (NDS)
Other DINs named EUTHYROX
- DIN 02264323 · Cancelled Post Market
- DIN 02264331 · Cancelled Post Market
- DIN 02264358 · Cancelled Post Market
- DIN 02264374 · Cancelled Post Market
- DIN 02264390 · Cancelled Post Market
- DIN 02264404 · Cancelled Post Market
- DIN 02264412 · Cancelled Post Market
- DIN 02264420 · Cancelled Post Market
- DIN 02264439 · Cancelled Post Market
- DIN 02264447 · Cancelled Post Market
- DIN 02264455 · Cancelled Post Market